This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.
Age range
21 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Cost-effectiveness in the novel approach in vaccinated and unvaccinated women less than 30 years old
Timeframe: Up to 4 years
Cost-effectiveness in the standard approach in vaccinated and unvaccinated women less than 30 years old
Timeframe: Up to 4 years
Overall cost-effectiveness and acceptability
Timeframe: Up to 4 years
Sensitivity and specificity for CIN 1+ of currently recommended in-clinic cytology screening
Timeframe: Up to 4 years
Sensitivity and specificity for CIN 1+ of novel home-based testing
Timeframe: Up to 4 years
Sensitivity and specificity of the novel approach in vaccinated women less than 30 years old
Timeframe: Up to 4 years
Sensitivity and specificity of the standard approach in vaccinated women less than 30 years old
Timeframe: Up to 4 years